Article Listing - Roche presses on with takeover, despite further rejection by Illumina board

ELI LILLY: DES SETTLEMENT

25 May 1992

- Eli Lilly has arrived at an out- of-court settlement with a New York woman, whose mother had taken the...

KYOWA HAKKO KOGYO: R&D PROJECTS

25 May 1992

- Kyowa Hakko Kogyo is to start autumn clinical studies on the carcinostatic Duocarmicin (kw-2189), its solid tumor treatment. The...

LOSEC SALES ROCKET FOR ASTRA

25 May 1992

Reporting first-quarter 1992 turn-over up 35% at 3.7 billion Swed-ish kroner, Sweden's Astra AB notes that sales of its proton...

ASTRA'S PLENDIL HEADING FOR CHF INDICATION

25 May 1992

Currently approved for use as an antihypertensive, Astra's third generation dihydropyridine vasoselective calcium channel blocker Plendil (felodipine) may also represent...

ASTRA TO FUND CMV TREATMENT STUDY

25 May 1992

Astra is to fund a comparative study of its Foscavir (foscarnet) and Syntex' Cytovene/Cymevene (ganciclovir) to determine which therapy is...

FDA PANEL'S POSITIVE REVIEW ON HALCION

25 May 1992

Following the US Food and Drug Administration's Psychopharmacol-ogical Drug Products Advisory Committee's conclusion that Upjohn's Halcion (triazolam) is safe and...

UK LAUNCH OF MERIEUX' TYPHIM Vi

25 May 1992

Announcing the forthcoming UK launch of the first single dose typhoid fever vaccine, Merieux UK Ltd has expressed confidence that...

JAPANESE DRUGMAKERS SET SALES AIMS

25 May 1992

A number of Japanese pharmaceutical companies are looking to good growth in the coming years, and are setting ambitious sales...

PROSPECTS FOR THE OTC MARKET IN ISRAEL

25 May 1992

Traditionally, the over-the-counter medicines market in Israel has not been of any significant size, but there have in recent times...

EC PARLIAMENT VOTES FOR DRUG PATENT EXTENSION

25 May 1992

The European Parliament approved the Merz report on the supplementary protection certificates for medicines at its plenary session in Stras-bourg...

Showing 94041-94050 of 95572 articles